Micah Luftig, PhD
Assistant Professor
bio  •  lab members  •  lab website

Representative Publications:

Luftig, M. A., M. Mattu, P. Di Giovine, E. Bianchi, M. D. Miller, R. Hrin, R. Geleziunas, G. Barbato, A. Pessi, A. Carfi. (2006). ”Structural basis of HIV-1 neutralization by a gp41 fusion-intermediate directed antibody.” Nat Struct Mol Biol. 13:740-7.

Johannsen, E., M. A. Luftig, M. Chase, S. Weicksel, E. C.-McFarland, D. Illanes, D. Sarracino, and E. Kieff. (2004). “Proteins of purified Epstein-Barr Virus.” PNAS. Nov 16;101(46):16286-91. 

Yasui, T., M. A. Luftig, V. Soni, and E. Kieff. (2004). “Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.” PNAS. 101(1):278-83.

Luftig, M. A., T. Yasui, V. Soni, M.S. Kang, N. Jacobson,E. Cahir-McFarland,B. Seed, and E. Kieff. (2004). “Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.” PNAS. 101(1):141-6.

Luftig, M. A., E. Prinarakis, T. Yasui, T. Tsichritzis, E. Cahir-McFarland, J. Inoue, H. Nakano, T. Mak, W. Yeh, X. Li, S. Akira, N. Suzuki, S. Suzuki, G. Mosialos, and E. Kieff. (2003). “Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.”  PNAS. 100(26):15595-600.

Luftig, M. A., E. Cahir-McFarland, G. Mosialos, and E. Kieff. (2001). "Effects of the NIK aly mutation on NF-kB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40." J. Biol.Chem. 276 (18): 14602-6.

Baghian, A., M. A. Luftig, J. B. Black, Y-X. Meng, C-P. Pau, T. Voss, P. E. Pellett, and K. G. Kousoulas. (2000). "Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino and carboxyl terminal fragments." Virology. 269(1):18-25.